Syneos Health, Inc. (NASDAQ: SYNH)

Engel Law PLLC is investigating whether fair value to Syneos Health, Inc. (NASDAQ: SYNH) shareholders will result from the proposed acquisition of Syneos by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital, for $43.00 per share in cash for each Syneos share.

The Firm’s investigation concerns:

(i) whether the Company’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction;
(ii) whether the merger consideration adequately compensates the Company’s shareholders; and
(iii) whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.

Join this Action

Syneos Health, Inc.

MM slash DD slash YYYY